VIADUR Drug Patent Profile
✉ Email this page to a colleague
When do Viadur patents expire, and when can generic versions of Viadur launch?
Viadur is a drug marketed by Ortho Mcneil Janssen and is included in one NDA.
The generic ingredient in VIADUR is leuprolide acetate. There are twenty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Viadur
A generic version of VIADUR was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
Summary for VIADUR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 19 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VIADUR |
DailyMed Link: | VIADUR at DailyMed |
Recent Clinical Trials for VIADUR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
ECOG-ACRIN Cancer Research Group | Phase 3 |
Jonsson Comprehensive Cancer Center | Phase 2 |
Janssen Inc. | Phase 2 |
US Patents and Regulatory Information for VIADUR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ortho Mcneil Janssen | VIADUR | leuprolide acetate | IMPLANT;IMPLANTATION | 021088-001 | Mar 3, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VIADUR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ortho Mcneil Janssen | VIADUR | leuprolide acetate | IMPLANT;IMPLANTATION | 021088-001 | Mar 3, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Ortho Mcneil Janssen | VIADUR | leuprolide acetate | IMPLANT;IMPLANTATION | 021088-001 | Mar 3, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Ortho Mcneil Janssen | VIADUR | leuprolide acetate | IMPLANT;IMPLANTATION | 021088-001 | Mar 3, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VIADUR
See the table below for patents covering VIADUR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2244997 | ADMINISTRATION PROLONGEE D'UN AGENT ACTIF A L'AIDE D'UN SYSTEME IMPLANTABLE (SUSTAINED DELIVERY OF AN ACTIVE AGENT USING AN IMPLANTABLE SYSTEM) | ⤷ Try a Trial |
China | 100506311 | ⤷ Try a Trial | |
Canada | 2315890 | MEMBRANES DE REGULATION DE DEBIT POUR DISPOSITIFS D'ADMINISTRATION REGULEE DE MEDICAMENTS (RATE CONTROLLING MEMBRANES FOR CONTROLLED DRUG DELIVERY DEVICES) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |